AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymche...
The globally active life science company Eppendorf SE is taking the next major step in expanding its international manuf...
Nippon Kayaku and Celltrion Healthcare Japan K.K. have entered into a Memorandum of Understanding (MoU) on Compreh...
Harbour BioMed, a US-based biopharmaceutical company, has entered into a strategic collaboration with China Nationa...
US-based Waters Corporation has announced the launch of the Xevo TQ Absolute XR IVD Mass Spectrometer, expanding it...
HoneyNaps has officially registered as a Contract Research Organization (CRO) with the Korea National Enterprise for Cli...
Hong Kong-based Home Control International has announced that its wholly-owned subsidiary, Orbiva has entered into ...
Japan-based Shimadzu Corporation has announced the release of the GCMS-TQ8040 RX and GCMS-TQ8050 RX gas chromatogra...
Takeda China has announced that the National Medical Products Administration (NMPA) has approved the use of ORZEYFUL (ov...
GCCL, a South Korea-based leading provider of clinical trial sample analysis, and China & US based GemPharmatech, a ...
Gerresheimer, an innovative system and solution provider and global partner to the pharma, biotech, and cosmetic industr...
M42’s National Reference Laboratory (NRL), a leading provider of diagnostic services in the region, has entered in...
Tikva Allocell, a Singapore-based biotechnology startup developing engineered, allogeneic (donor-derived) cell therapies...
JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies for rare and gen...
Fangzhou Inc. has announced the launch of Kyinsu®, the world's first once-weekly basal insulin/GLP-1 RA combination ...
South Korea-based Samsung Biologics has announced the launch of an all-cash public tender offer to acquire 100% of the f...
Galderma has announced the launch of Alastin – its premium regenerative skincare brand – across the JPAC reg...
Merck, a leading science and technology company, has opened a new €25 million BioReliance® testing facility at ...
Menarini Asia-Pacific has announced an exclusive partnership with Pharmacosmos A/S to register, commercialise and distri...
AstraZeneca has entered into an exclusive license agreement with China-based Dizal Pharmaceutical for Zegfrovy ...
India's Sai Parenterals has announced that its Australian subsidiary, Noumed Pharmaceuticals, has successfully renewed i...
How does CT fit into your overall regional expansion strategy, especially in emerging markets like India and Southeast A...
Telix Pharmaceuticals has officially opened a multi-million dollar radiopharmaceutical research, manufacturing and treat...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Japan-based Shimadzu Corporation has completed the acquisition of all shares of Glass HoldCo s.r.o., which indirectly ho...
